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To elucidate the role of astrocytes in the stress re-
sponse of the central nervous system to ischemia, early
gene expression was evaluated in cultured rat astro-
cytes subjected to hypoxia/reoxygenation. Using differ-
ential display, a novel putative vesicle transport-related
factor (RA410) was cloned from reoxygenated astro-
cytes. Analysis of the deduced amino acid sequence
showed RA410 to be composed of domains common to
vesicle transport-related proteins of the Sec1/Unc18
family, including Sly1p and Sec1p (yeast), Rop (Drosoph-
ila), Unc18 (Caenorhabditis elegans), and Munc18 (mam-
malian), suggesting its possible role in vesicular trans-
port. Northern analysis of normal rat tissues showed the
highest expression of RA410 transcripts in testis. When
astrocyte cultures were subjected to a period of hypoxia
followed by reoxygenation, induction of RA410 mRNA
was observed within 15 min of reoxygenation, reaching
a maximum by 60 min. At the start of reoxygenation, the
addition of diphenyl iodonium, an NADPH oxidase in-
hibitor, blocked in parallel astrocyte generation of reac-
tive oxygen intermediates and expression of RA410 mes-
sage. In contrast, cycloheximide did not affect RA410
mRNA levels, indicating that RA410 is an immediate-
early gene in the setting of reoxygenation. Using poly-
clonal antibody raised against an RA410-derived syn-
thetic peptide, Western blotting of lysates from reoxy-
genated astrocytes displayed an immunoreactive band of
'70 kDa, the expression of which followed induction of
the mRNA. Fractionation of astrocyte lysates on sucrose
gradients showed RA410 antigen to be predominantly in
the plasma membrane. Immunoelectron microscopic
analysis demonstrated RA410 in large vesicles associated
with the Golgi, but not in the Golgi apparatus itself, con-
sistent with its participation in post-Golgi transport. Con-
sistent with these in vitro data, RA410 expression was
observed in rat brain astrocytes following transient oc-
clusion of the middle cerebral artery. These data provide
insight into a new protein (RA410) that participates in
the ischemia-related stress response in astrocytes.
Changes in the cellular microenvironment, especially those
that challenge cell viability, such as glucose deprivation, hy-
poxia, and accumulation of toxic metabolites, are major con-
tributors to tissue damage consequent to cerebral ischemia (1).
Adaptation to such circumstances leads to a change in the
cellular phenotype due, at least in part, to redirection of bio-
synthetic properties with expression of stress proteins. The
latter are central to the cellular stress response; global inhibi-
tion of their expression results in cell death in the altered
environment (2).
Because of their abundance and ability to sustain environ-
mental perturbations, astrocytes have an important role in
maintaining neuronal function under homeostatic and patho-
logic conditions (3). For example, astrocytes subjected to hy-
poxia, a major component of the ischemic milieu, express stress
proteins such as the 78-kDa glucose-regulated protein (GRP78)
(4) and the 150-kDa oxygen-regulated protein (ORP150) (5).
Induction of these stress proteins in response to hypoxia is
indicative of the capacity of astrocytes to maintain biosynthetic
processes, albeit redirected toward different products, in the
setting of oxygen deprivation.
In contrast to oxygen deprivation, reoxygenation, an abrupt
restoration of ambient oxygen tension in the cellular environ-
ment after a period of hypoxia, triggers a quite different cellu-
lar response. Since the period of reoxygenation is that most
closely associated with damage to parenchymal cells (6), we
reasoned that astrocytes would rise to the challenge of ische-
mia/reperfusion by redirecting cellular activities in support of
the more vulnerable population of neurons (7). Furthermore,
inhibition of protein synthesis at the time of reoxygenation,
even though it transiently increases the pool of high energy
phosphate compounds, ultimately results in failure to adapt to
the oxygen-rich environment and subsequent cell death (8).
We have previously described the cloning of a novel RNA-
binding protein expressed by reoxygenated astrocytes, suggest-
ing that changes in RNA processing/editing may be important
in the cellular response to ischemia (9). Here, we have identi-
fied another novel polypeptide (RA410), a vesicle transport-
related protein, also induced in reoxygenated astrocytes. Our
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data demonstrate that RA410 is expressed intensely in astrog-
lia in ischemic brain, and its subcellular localization suggests a
role in post-Golgi protein processing.
MATERIALS AND METHODS
Cell Culture and Exposure to Hypoxia/Reoxygenation—Rat primary
astrocytes were obtained from neonatal rats by a modification of a
previously described method (7). In brief, cerebral hemispheres were
harvested from neonatal Harlan Sprague Dawley rats within 24 h of
birth, and brain tissue was digested at 37 °C using Dispase II (3 mg/ml;
Boehringer, Mannheim, Germany). The mixture was plated in 175-cm2
culture flasks (two brains/flask), and cells were grown in minimal
essential medium supplemented with fetal calf serum (10%; CellGrow,
Life Technologies Inc.). After 10 days, culture flasks were incubated for
48 h with cytosine arabinofuranoside (10 mg/ml; Wako Chemicals,
Osaka, Japan) to prevent fibroblast overgrowth and agitated on a
shaking platform (Bioshaker BR-30L, Taitek, Tokyo, Japan) to separate
astrocytes from remaining microglia and oligodendroglia, and the ad-
herent cell population was then identified by morphologic and immu-
nohistochemical criteria (detection of glial fibrillary acidic protein).
Cells were then replated at a density of 5 3 104 cells/cm2 in the above
medium. When cultures achieved confluence, they were exposed to
hypoxia using an incubator attached to a hypoxia chamber that main-
tained a humidified atmosphere with low oxygen tension (Coy Labora-
tory Products, Grass Lake, MI), as described previously (10). Where
indicated, after exposure to hypoxia, cultures were returned to the
ambient atmosphere (reoxygenation), at which time the conditioned
medium was rapidly exchanged with fresh medium. Oxygen tension in
the medium was monitored using a blood gas analyzer (ABL-2, Radi-
ometer, Stockholm, Sweden). Cell viability was assessed by several
methods, including morphologic criteria, trypan blue exclusion, and
lactose dehydrogenase release.
Preparation of Total RNA and cDNA—Total RNA was extracted and
purified from astrocytes ('5 3 108 cells) exposed to hypoxia for 24 h or
to hypoxia/reoxygenation (24 h of hypoxia followed by 1 h of reoxygen-
ation) using the acid guanidinium/phenol/chloroform method (11). For
hypoxic samples, RNA extraction was performed inside the hypoxia
chamber after all reagents were equilibrated in the hypoxic atmo-
sphere. Then, purified RNA ('3 mg) was reverse-transcribed with Molo-
ney murine leukemia virus reverse transcriptase (300 units; Life Tech-
nologies, Inc.), oligo(dT) primer (2.5 mM T11GT), and dNTP mixture (20
mM each) for 60 min at 37 °C. cDNAs synthesized from RNAs were
subjected to differential display (see below).
Differential Display—The polymerase chain reaction (PCR),1 recov-
ery, and reamplification of cDNAs obtained from astrocytes exposed to
hypoxia and hypoxia/reoxygenation were performed as described (12)
with minor modifications. In brief, reverse transcriptase products ob-
tained from total RNA ('25 ng in each reaction) were used as PCR
templates in 30 ml of reaction mixture containing arbitrary primer (1
mM), dNTP (200 mM each), and Taq polymerase (2 units of AmpliTaq;
Takara Shuzo, Tokyo, Japan). Thermocycling was performed for 39
cycles with the indicated parameters (95 °C for 30 s, 40 °C for 1 min,
and 72 °C for 1 min (5 min for last cycle)) using the same arbitrary
12-mer oligonucleotide as both the upstream and downstream primers.
In one set of experiments, PCR products obtained from hypoxic and
hypoxic/reoxygenated astrocytes were screened using 60 different prim-
ers. After separation by 5% polyacrylamide gel electrophoresis, PCR
products were visualized by staining with ethidium bromide. cDNA
bands specifically amplified in hypoxic/reoxygenated astrocytes were
excised and eluted from the gels. Then, the eluted material was ream-
plified by PCR using the same primers and conditions employed in
differential display except for an increased concentration of dNTP
mixture (40 mM).
Cloning and Sequencing of cDNA Fragments—Reamplified cDNA
fragments were cloned into the pT7Blue T-vector (Novagen, Madison,
WI). Plasmid DNA sequencing of cloned fragments was carried out
using the Taq Dye Primer Cycle Sequencing Core kit (Applied Biosys-
tems Inc., Tokyo, Japan) with either the M13 forward sequencing
primer or reverse primer. The cDNA sequences were analyzed and
compared for homology with those available in the EMBL and Gen-
Bank™ DNA data bases and the SWISSPROT protein data base. One of
the cDNA fragments, tentatively named RA410, was subjected to fur-
ther analysis. A rat cDNA library was screened allowing isolation of a
cDNA (2 kilobase pairs) that encompassed the entire open reading
frame of RA410. The latter was sequenced in both directions. To show
homology to other vesicle transport-related proteins, phylogenic tree
analysis was performed as described (13).
Northern Analysis—To study induction of RA410 transcripts during
reoxygenation, Northern blot analysis was performed using a cDNA
probe synthesized from an RA410 fragment as described previously (9).
In brief, total RNA extracted from hypoxic or hypoxic/reoxygenated
astrocytes ('5 mg) by the acid guanidinium/phenol/chloroform method
was subjected to formaldehyde-agarose (1%) gel electrophoresis and
transferred overnight to Immobilon N membranes (Millipore Corp.,
Bedford, MA). RNA was fixed to the membrane by exposure to UV
irradiation prior to hybridization with cDNA probes. The membrane
was prehybridized for 3 h at 65 °C in hybridization buffer (6 3 SSC (0.9
M NaCl and 90 mM sodium citrate, final pH 7.0), 5 3 Denhardt’s
solution (0.5% Ficoll, 0.5% polyvinylpyrrolidone, and 0.5% bovine serum
albumin), 0.5% SDS, and 100 mg/ml heat-denatured salmon sperm
DNA). The membrane was probed with 32P-labeled cDNA fragments of
RA410 by the random hexamer procedure (14). After hybridization,
filters were washed twice with 2 3 SSC and 0.5% SDS and with 0.1 3
SSC and 0.5% SDS for 30 min at 65 °C, exposed to x-ray film (Kodak
X-Omat, Eastman Kodak Co.), and subjected to autoradiography. In-
duction of RA410 mRNA was evaluated by comparison with b-actin
mRNA. In some experiments, either cycloheximide (10 mg/ml) or di-
phenyl iodonium (DPI) (50 mM; both reagents from Sigma) was added to
the culture 15 min prior to reoxygenation, and total RNA was extracted
30 min after reoxygenation. To access the distribution of RA410 tran-
scripts under normal conditions, RNA was prepared and purified from
adult Harlan Sprague Dawley rats (200–300 g) by the method described
previously (15), and Northern blot analysis was performed as described
above.
Production of Anti-RA410 Peptide Antibody and Western Blot-
ting—To obtain antibody reactive with RA410 antigen, a peptide with
the sequence CQEDEVKRLKSIMGLEGEDE (amino acids 346–365;
see Fig. 1B), which contains an extra cysteine residue at the N terminus
to facilitate conjugation, was synthesized and conjugated to bovine
serum albumin using a kit from Sigma. Rabbits were immunized by
conventional methods, and antisera were obtained from two rabbits,
each immunized with 1 mg of synthetic peptide. Antibody titers of these
antisera were studied by enzyme-linked immunosorbent assay, and the
IgG fraction was purified by affinity chromatography using a column
with immobilized RA410-derived synthetic peptide (ProtOn Kit1, Mul-
tiple Peptide Systems). Astrocytes ('106 cells) exposed to hypoxia/
reoxygenation for the indicated times were washed three times with
phosphate-buffered saline, pelleted, and lysed in buffer containing 1%
Nonidet P-40. Samples were prepared for SDS-polyacrylamide gel elec-
trophoresis (10%; 5 mg of protein/lane), and RA410 antigen was visual-
ized by immunoblotting (16) using anti-RA410 IgG. Protein content was
determined using the Bio-Rad microprotein assay kit.
Subcellular Localization of RA410—To localize RA410 antigen in
reoxygenated astrocytes, cells ('108) were exposed to hypoxia (24 h)/
reoxygenation (3 h) and harvested by centrifugation, and the cell pellet
was disrupted by Dounce homogenization. Fractionation of cell lysates
was performed as described (17), and following measurement of protein
concentration, each fraction ('5 mg of protein) was immunoblotted with
anti-RA410 IgG. Immunocytochemical studies were performed on ei-
ther hypoxic or reoxygenated astrocytes as described (18). In brief,
astrocytes plated on glass coverslips (ChamberSlide, Nunc Inc., Naper-
ville, IL) were exposed either to hypoxia (24 h)/reoxygenation (3 h) or to
hypoxia only (24 h), fixed in Zamboni buffer for 2 h, washed twice with
0.2 M phosphate-buffered saline, and incubated with either anti-RA410
IgG or preimmune rabbit IgG (10 mg/ml in each case). Sites of primary
antibody binding were visualized using fluorescein isothiocyanate-con-
jugated anti-rabbit IgG (Sigma).
To further analyze the subcellular localization of RA410 antigen in
hypoxic astrocytes, cells ('5 3 108) were pelleted and fractionated as
described (19). In brief, astrocyte cell pellets frozen at 280 °C were
thawed and resuspended in 10 ml of buffer A (0.25 M sucrose, 10 mM
HEPES/NaOH, pH 7.5, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl
fluoride, 1 mg/ml leupeptin, and 0.1 mM Na-p-tosyl-L-lysine chloro-
methyl ketone), and the cells were cavitated at 400 p.s.i. N2 pressure for
30 min by nitrogen cavitation bomb (Kontes Glass Co., Vineland, NJ).
Following homogenization, the cell lysate was clarified by centrifuga-
tion at 10,000 3 g for 15 min at 4 °C, and the pellet was resuspended in
10 mM Tris-HCl, pH 8.0, 1% Nonidet P-40, 150 mM NaCl, 1 mM EDTA,
10 mg/ml aprotinin, and 1 mM phenylmethylsulfonyl fluoride. The clar-
ified lysate was then centrifuged and fractionated by a series of sucrose
steps: 38, 30, and 20% sucrose (all prepared in 10 mM HEPES/NaOH,
pH 7.5, and 1 mM dithiothreitol) at 100,000 3 g for 3 h at 4 °C. Layered
1 The abbreviations used are: PCR, polymerase chain reaction; DPI,
diphenyl iodonium; IL, interleukin.
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FIG. 1. RA410: expression of mRNA in astrocytes subjected to hypoxia/reoxygenation (A), predicted amino acid sequence (B),
homology to other vesicle transport polypeptides (C), and phylogenic tree analysis (D). In A, RNA was extracted and pooled from three
different astrocyte cultures. About 5 mg of RNA from normoxic (lane N), hypoxic (lane H), or reoxygenated (lane H/R) cultures was subjected to
Northern blot hybridization using [32P]dCTP-labeled RA410 cDNA probe (upper panel) and b-actin probe (lower panel). In B, the amino acid
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fractions (fractions 1–4) were collected by puncturing the tube at the
desired depth and gently withdrawing the fluid. The pellet at the
bottom of the tube was resuspended in 3 ml of buffer A (precipitate
fraction 5). Following measurement of protein concentration, each frac-
tion ('5 mg of protein) was subjected to Western blotting using anti-
RA410 IgG. Enrichment of cellular structures/organelles in subcellular
fractions was identified by the presence of marker enzymes: alkaline
phophodiesterase I (plasma membrane), a-mannosidase II (Golgi appa-
ratus), and dolichol-P-mannose synthetase (endoplasmic reticulum)
(19).
Immunoelectron microscopic analysis to identify RA410 antigen
within reoxygenated astrocytes was performed as described (20). In
brief, cultured astrocytes exposed to hypoxia (24 h)/reoxygenation (3 h)
were fixed in Zamboni buffer for 2 h, washed twice with 0.2 M phos-
phate-buffered saline, and incubated with either anti-RA410 IgG or
preimmune rabbit IgG (10 mg/ml in each case). Sites of primary anti-
body binding were identified with biotinylated goat anti-rabbit IgG
following reaction with avidin-biotin-peroxidase complex (Vector Labs,
Inc.) and staining with diaminobenzidine and uranyl acetate. Tissues
were then flat-embedded in Epon 812, and ultrathin sections were
stained with lead citrate, followed by observation at 75 kV on an H-600
electron microscope (Hitachi, Tokyo, Japan).
Assay of NADPH Oxidase Activity—Cell-surface NADPH activity
was measured as described (21) by incubating astrocytes (5 3 107 cells)
for 3 h at 37 °C in 2 ml of phosphate-buffered saline, 5 mM CaCl2, and
5 mg/ml cytochrome c. Where indicated, DPI (50 mM), an inhibitor of
neutrophil-type NADPH oxidase, was added to the incubation mixture.
Following the incubation period, cell suspensions were centrifuged
(1000 3 g for 5 min), and absorbance at 540 nm in the supernatant was
measured using a Model UV-160 spectrophotometer (Shimadzu, Kyoto,
Japan). Superoxide production was determined based on the difference
in absorbance at 540 nm in the absence and presence of superoxide
dismutase (1 mg/ml; Sigma).
Expression of RA410 in Ischemic Brain—Expression of RA410 anti-
gen was studied following transient unilateral (2 h) occlusion of the
middle cerebral artery in male Harlan Sprague Dawley rats (250 g) (22).
Blood gases, pH, and mean arterial blood pressure were monitored
throughout the operation. Experiments were completed only if these
physiological variables remained within normal limits. The normal
limits for these parameters were set as follows: mean arterial blood
pressure, 90–130 mm Hg; PCO2, 30–50 mm Hg; PO2, 100–130 mm Hg;
and arterial blood pH, 7.25–7.45. Six hours after termination of arterial
occlusion, rats were perfusion-fixed with 4% paraformaldehyde. Serial
coronal sections (20-mm thickness) were obtained using a vibratome
and were appropriately prepared and stained with anti-RA410 IgG. The
same sections was further stained with anti-glial fibrillary acidic pro-
tein antibody (23), followed by visualization of the primary antibody
using fluorescein isothiocyanate-labeled secondary antibody. Where in-
dicated, anti-RA410 IgG was preincubated with excess antigen (10 mM
RA410-derived peptide) for 12 h at 4 °C prior to its incubation with
tissue sections.
RESULTS
Viability of Astrocytes Exposed to Hypoxia/Reoxygenation—
Oxygen tension in the medium fell to 8 torr within 3–5 h after
cultures were transferred to the hypoxia chamber. Cell viabil-
ity was maintained throughout hypoxia and following return of
cultures to normoxia (reoxygenation). This conclusion is based
on lack of lactose dehydrogenase release into culture superna-
tants, continued trypan blue exclusion, adherence to the cul-
ture substrate, and unchanged morphologic features (data not
shown).
Isolation of the cDNA for RA410 by Differential Display—
Using the primer 59-TGG TAC GGT ATA-39 for differential dis-
play, a portion of a cDNA, termed RA410, was amplified from
the cDNAs prepared from pooled RNA of hypoxia/reoxygenated
astrocytes. A full-length cDNA was then isolated. Northern
blotting using 32P-labeled RA410 cDNA probe confirmed the
presence of the transcripts in RNA pools obtained from reoxy-
genated astrocytes (Fig. 1A). The apparent migration of the
band corresponded to 2.0 kilobase pairs, suggesting that the
cDNA (also 2 kilobase pairs) was likely to be full-length. The
deduced amino acid sequence, derived from nucleotide sequenc-
ing of the RA410 cDNA, included 637 amino acids (Fig. 1B) and
resulted in a predicted polypeptide molecular mass of '70 kDa.
Comparison with data bases indicated the presence of a con-
sensus sequence associated with vesicle transport-related fac-
tors (Fig. 1, C and D). Of known vesicle transport proteins,
RA410 had greatest homology (38%) to Sly1p (24), a yeast
vesicle transport-related factor (Fig. 1, C and D). In addition,
similarities were observed to Sec1p (yeast) (25), Vps45p (yeast)
(26), Vps33p (yeast) (27), Munc18 (rat) (28), Rop (Drosophila
melanogaster) (29), Unc18 (Caenorhabditis elegans) (30),
b-COP (human) (31), and HSC70 (human) (32).
FIG. 2. Expression of RA410 mRNA (A) and RA410 antigen (B)
in cultured astrocytes subjected to hypoxia/reoxygenation. In A,
total RNA was extracted from astrocytes at the end of hypoxia (0 h, the
time at which reoxygenation was begun) and at the indicated time
points after the start of reoxygenation (0.5–24 h). Then, '5 mg of total
RNA was subjected to Northern analysis as described in the legend to
Fig. 1A. In B, astrocytes exposed to hypoxia (Hypo; 0–24 h) followed by
reoxygenation (Reoxy; 2–24 h) were harvested, and protein extracts ('5
mg) were subjected to reducing SDS-polyacrylamide gel electrophoresis
(10%) followed by immunoblotting with anti-RA410 polyclonal antibody
(10 mg/ml). The migration of standard proteins is indicated on the
left: carbonic anhydrase (31 kDa), ovalbumin (45 kDa), bovine serum
albumin (66 kDa), phosphorylase b (97.4 kDa), b-galactosidase
(116 kDa), and myosin (200 kDa). N, normoxia; H, hypoxia; H/R,
hypoxia/reoxygenation.
FIG. 3. Distribution of RA410 mRNA in normal tissue. Total
RNA was prepared from various tissues (brain (B), heart (H), small
intestine (In), kidney (Ki), lung (Lu), spleen (Sp), testis (Te), and thy-
mus (Th)), and ;5 mg of total RNA was subjected to Northern analysis
as described in the legend to Fig. 1A.
sequence predicted from the cDNA of RA410 (upper line) is compared with that of Sly1p (lower line), a yeast vesicle transport peptide. Identical
amino acid residues in each peptide are indicated by asterisks. In C, the predicted amino acid sequence of RA410 (residues 253–279) is compared
with the consensus sequences of other vesicle transporters. The consensus sequences of these vesicle transport-related proteins are indicated in
the lower panel. In D, phylogenic analysis of the multiple alignment is shown. The tree is rooted assuming a clock, which might not be justified.
The number in the tree represents the exact length of each branch, which is roughly proportional to the horizontal lines.
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Induction of RA410 in Cultured Astrocytes by Hypoxia/
Reoxygenation—Northern blot analysis of RNA from cultured
astrocytes using 32P-labeled RA410 cDNA probe showed a
striking increase in transcripts within 0.5 h of reoxygenation;
levels of RA410 mRNA reached a plateau within 0.5–1 h and
subsequently declined to the base line by 24 h (Fig. 2A). Poly-
clonal antibody raised against a synthetic peptide derived from
the predicted RA410 protein sequence recognized a band in
lysates of reoxygenated astrocytes of '70 kDa (Fig. 2B). This is
close to the expected molecular mass ('70 kDa) based on the
sequence deduced from full-length RA410 cDNA. The specific-
ity of this immunoreactive band for RA410 was confirmed by its
disappearance when antibody was preincubated with excess
RA410-derived synthetic peptide (data not shown). Expression
of RA410 antigen occurred within 2 h of reoxygenation,
achieved a maximum by 4–8 h, and returned to base line
within 24 h, consistent with the pattern of RA410 message
expression (Fig. 2B).
Distribution of RA410 Message in Normal Tissue—Northern
blot analysis using RNA obtained from normal rat tissue re-
vealed the distribution of RA410 transcripts to be highest in
testis, with lower levels in heart, intestines, and brain (Fig. 3).
Localization of RA410 in Reoxygenated Astrocytes—To local-
ize RA410 antigen in reoxygenated astrocytes, fractionated cell
lysates prepared from reoxygenated cultures were subjected to
immunoblotting using anti-RA410 IgG. RA410 antigen was
detected mainly in the membrane fraction (Fig. 4A). Sucrose
gradient separation of cytosolic fractions also showed RA410
antigen mainly in the plasma membrane and partially in the
Golgi subfraction (Fig. 4B). These data were consistent with
the results of immunocytochemical analysis of cultured astro-
cytes using anti-RA410 IgG (Fig. 5A); hypoxic/reoxygenated
astrocytes demonstrated RA410 antigen, whereas no signifi-
cant staining was detected in astrocytes subjected to hypoxia
alone (Fig. 5B). Controls in which hypoxic/reoxygenated astro-
cytes were stained with preimmune IgG displayed no staining
(Fig. 5C).
Immunoelectron microscopic analysis using anti-RA410 IgG
in astrocytes exposed to hypoxia/reoxygenation revealed label-
ing of the antigen in large vesicles associated with the Golgi
apparatus (Fig. 6A) and in the processes of astrocytes (Fig. 6B),
but not in the Golgi apparatus itself. This is consistent with the
results of Western blotting of subcellular fractions (Fig. 4, A
and B) and suggests that RA410 may participate in post-Golgi
vesicle transport.
Generation of Superoxide in Reoxygenated Astrocytes and
Expression of RA410—To assess mechanisms underlying ex-
pression of RA410 in astrocytes exposed to hypoxia/reoxygen-
ation, elaboration of superoxide was measured using the cyto-
FIG. 4. Localization of RA410 peptide in cultured rat astro-
cytes after reoxygenation. A, subcellular fractionation of hypoxic
astrocyte lysates. Astrocytes ('108 cells) were exposed to hypoxia/
reoxygenation, harvested by centrifugation, and fractionated as de-
scribed under “Materials and Methods.” Fractions ('5 mg of protein)
were subjected to immunoblotting using anti-RA410 antibody. The
lanes show fractions containing crude nuclear pellet (lane 1), purified
nuclei (lane 2), nuclear debris (lane 3), purified nuclear extract (lane 4),
nuclear wash (lane 5), cytosolic membranes (lane 6) and protein (lane 7),
membranes (lane 8), membrane wash (lane 9), or washed membrane
pellet (lane 10). B, sucrose density gradient centrifugation of hypoxic/
reoxygenated astrocyte lysates. Cavitates of reoxygenated astrocytes
('5 3 108 cells) were separated by sucrose gradient centrifugation as
described under “Materials and Methods.” Each fraction ('5 mg of
protein) was immunoblotted using anti-RA410 IgG. The lanes represent
fractions containing cytosol (lane 1), plasma membrane (lane 2), Golgi
(lane 3), and endoplasmic reticulum (lanes 4 and 5). The migration of
simultaneously run molecular mass markers (in kilodaltons) is shown
on the left.
FIG. 5. Immunocytochemical analysis of hypoxic astrocytes.
Astrocytes plated on coverslips were exposed either to hypoxia (24
h)/reoxygenation (3 h) (A and C) or to hypoxia alone (24 h) (B), perme-
abilized, and incubated either with anti-RA410 IgG (A and B) or with
preimmune IgG (C). Sites of primary antibody binding were detected
using fluorescein isothiocyanate-conjugated anti-rabbit IgG. Magnifica-
tion 3 400.
FIG. 6. Immunoelectron microscopic analysis of RA410. Cul-
tured astrocytes were exposed to hypoxia (24 h)/reoxygenation (3 h),
followed by staining with anti-RA410 antibody. Immunodeposits were
observed corresponding to sites of RA410 antigen in large vesicles
associated with the Golgi apparatus (g) (A) and in the processes of
astrocytes (indicated by arrows) (B). Magnification x 10,000.
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chrome c assay; superoxide generation was measured as the
component of cytochrome c reduction suppressed on addition of
superoxide dismutase. Superoxide was formed almost immedi-
ately after reoxygenation and was suppressed in a dose-de-
pendent manner by DPI (Fig. 7A). In contrast, astrocytes ex-
posed to either hypoxia or normoxia alone demonstrated no
superoxide generation (Fig. 7A). Expression of RA410 mRNA in
reoxygenated astrocytes was blocked by pretreatment of astro-
cytes with DPI (50 mM) in parallel with suppression of reactive
oxygen intermediate formation (Fig. 7B). The addition of an-
tagonists of nitric-oxide syntheses, such as methyl-nitro N-nitro
L-arginine, or placing cultures in arginine-free medium had no
affect on cytochrome c reduction or expression of RA410
mRNA, indicating that DPI exerted its effect most likely by
inhibiting an NADPH oxidase-like activity, rather than by
interfering with formation of nitric oxide (data not shown). The
addition of cycloheximide to astrocytes, sufficient to diminish
incorporation of [3H]leucine into a fraction precipitable in tri-
chloroacetic acid by .90%, did not diminish the level of RA410
message, suggesting that RA410 expression might reflect an
immediate early-type mechanism in reoxygenated astrocytes
triggered by superoxide produced as a consequence of activa-
tion of an NADPH-like activity.
Expression of RA410 Immunoreactivity in Ischemic Rat
Brain—To evaluate expression of RA410 in vivo, immunohis-
tochemical analysis was performed on mouse brain following
transient unilateral occlusion of the middle cerebral artery. At
lower power, staining of ipsilateral ischemic cortex was ob-
served (Fig. 8A), whereas contralateral nonischemic cortex
(control) was negative (Fig. 8B). Higher power views of adja-
cent sections of ischemic cortex display colocalization of RA410
antigen (Fig. 8D), with cells also staining for glial fibrillary
acidic protein (Fig. 8E). In contrast, samples of ischemic cortex
stained with anti-RA410 IgG in the presence of excess peptide
used as immunogen showed no staining (Fig. 8C), indicating
that staining of RA410 (Fig. 8D) was specific.
DISCUSSION
Astrocytes have a central role in the maintenance of central
nervous system homeostasis through modulation of the ionic
milieu, removal of excitatory neurotransmitters, and mainte-
nance of the blood-brain barrier (33–35). In addition to these
housekeeping activities, neurotrophic properties of astrocytes
support neuronal differentiation and survival through produc-
tion of growth factors, such as nerve growth factor, basic fibro-
blast growth factor, and ciliary neurotrophic factor (36–38).
Another facet of astrocyte biology concerns their ability to
adapt to environmental stress, such as that represented by
ischemia/reperfusion, modeled in our studies by hypoxia/reoxy-
genation. In contrast to the vulnerability of neurons to changes
in ambient conditions, external challenges allow astrocytes to
undergo activation, resulting in a change in cellular phenotype,
as in tissue remodeling in the central nervous system (39).
Consistent with this view, astrocytes have produced cytokines,
including interleukin (IL)-1, IL-6, interferons, and transform-
ing growth factor-b, in response to changes in the cellular
environment, allowing them to orchestrate a cytokine cascade
in brain (40).
We have previously demonstrated that expression of IL-6, a
potent neurotrophic cytokine in the central nervous system,
occurs in cultured astrocytes exposed to hypoxia/reoxygenation
(7). Although induction of IL-6 mRNA is initiated late during
hypoxia, maximal transcription, translation, and elaboration of
this cytokine does not begin until reoxygenation, leading us to
hypothesize that reoxygenation sets in motion a series of
events culminating in astrocyte expression of a neurotrophic
phenotype. We have delineated several components of this
potential pathway. RA301, a Drosophila Tra-2-like RNA-splic-
ing factor, also first identified using differential display applied
to hypoxic/reoxygenated astrocytes, is likely to contribute to
maturation of nascent RNAs, as its expression was necessary
for maximal IL-6 production by the reoxygenated astrocyte (9).
FIG. 7. Generation of superoxide in cultured astrocytes after
reoxygenation (A) and effect of DPI on induction of RA410 mes-
sage (B). A, superoxide generation by astrocytes (5 3 107 cells) during
the first 3 h of reoxygenation (R) following a 24-h period of hypoxia was
measured using the cytochrome c reduction assay by determining the
difference in absorbance at 540 nm in the absence and presence of
superoxide dismutase (1 mg/ml; this difference is shown by the first bar).
Suppression of superoxide generation on addition of DPI (25–50 mM) to
astrocytes subjected to hypoxia/reoxygenation as described above is
shown. Superoxide generation by astrocytes exposed to hypoxia (H) (24
h) or normoxia (N) alone is also shown. For these experiments, n 5 6,
and the mean 6 S.D. is shown. B, cycloheximide (Cx; 10 mg/ml) or DPI
(50 mM) was added to the culture 15 min before reoxygenation, and at
the indicated times, total RNA was harvested and subjected to North-
ern blot analysis. Astrocyte RNA was obtained at the end of hypoxia
(lane 0) or 15 and 60 min after reoxygenation.
FIG. 8. Expression of RA410 antigen in ischemic brain. Immu-
nohistochemical analysis was performed on rat brain 1 h after unilat-
eral occlusion of the middle cerebral artery for 2 h. Ipsilateral cerebral
cortex (ipsi) was reacted with anti-RA410 antibody (A, magnification 3
4; and D, magnification 3 40). Adjacent sections were also analyzed
with anti-RA410 IgG in the presence of RA410 synthetic peptide (C,
magnification 3 40). The same section used in D was further stained
with anti-glial fibrillary acidic protein (GFAP) antibody, followed by
detection with fluorescein isothiocyanate-labeled secondary antibody
(E, magnification 3 40). Contralateral nonischemic cortex (contra) was
also stained with anti-RA410 antibody (B, magnification 3 4).
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The 78-kDa glucose-regulated protein (GRP78/BiP), a major
stress protein in astrocytes expressed in response to oxygen
deprivation, functions as a molecular chaperone by retaining
immature IL-6 in the endoplasmic reticulum until the cellular
metabolic environment is restored (8). RA410, likely to be a
vesicle transport-related polypeptide, is also a potential con-
tributor to protein trafficking in response to cellular stress. In
this context, RA410 has the greatest homology to Sly1p, a yeast
polypeptide that has a major role in vesicle transport and
protein secretion (41). Our pilot studies are consistent with this
concept and demonstrate that suppression of RA410 expression
causes intracellular (Golgi) retention of IL-6, suggesting that
this polypeptide is required for optimal trafficking of IL-6
through hypoxic/reoxygenated astrocytes.
Expression of RA410 mRNA is enhanced by inhibition of
protein synthesis using cycloheximide, suggesting an immedi-
ate early-type mechanism. In this case, the stimulus for expres-
sion of this vesicle transport-related factor appears to reside in
reoxygenation-mediated activation of an NADPH-like activity
with subsequent generation of superoxide. Similarly, reoxygen-
ation-associated induction of RA301 is also regulated by reac-
tive oxygen intermediates; the addition of the NADPH oxidase
inhibitor diphenyl iodonium resulted in a marked decline in
RA301 message/RA301 antigen in cultured astrocytes (9). Our
pilot studies demonstrate that the level of IL-6 transcripts is
not suppressed by NADPH oxidase inhibitors, suggesting that
diphenyl iodonium exerts its effect(s) at steps distal to
transcription/mRNA stability. Such regulation appears to in-
volve, at least in part, expression of RA301 and RA410. These
data provide insight into the complex events activated in as-
trocytes by hypoxia/reoxygenation. In addition, a role for reac-
tive oxygen intermediates as signal transducers of the stress
signal is emphasized, analogous to their role in NF-kB activa-
tion (42).
In summary, we have cloned and characterized a novel ves-
icle transport-related factor, RA410, from hypoxic/reoxygen-
ated astrocytes. Such expression of RA410 is regulated by the
generation of reactive oxygen intermediates by an NADPH
oxidase-like activity. Expression of RA410 in cultured astro-
cytes subject to environmental stress suggests that the mark-
edly enhanced protein synthesis that occurs at this time rep-
resents a redirection of the biosynthetic apparatus to facilitate
expression and release of new gene products.
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